Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Net Sales $ 9,000 $ 8,000
Operating Expenses:    
Cost of Revenue 30,000 1,000
Research and development 564,000 130,000
General and administrative 2,189,000 5,269,000
Total operating expenses (2,783,000) (5,400,000)
Loss from operations (2,774,000) (5,392,000)
Other income (expense)    
Other Income / (Expense) (5,000)
Financing costs (84,000) (172,000)
Interest expense - amortization of debt discount (1,054,000) (748,000)
Change in fair value of derivative liability 944,000 (2,625,000)
Debt extinguishment, net 652,000
Interest expense (including $35,000 and $58,000 to related parties) (40,000) (204,000)
Total other expense (234,000) (3,102,000)
Net Loss $ (3,008,000) $ (8,494,000)
Loss per share - basic and diluted $ (0.25) $ (1.00)
Weighted average number of common shares outstanding - basic and diluted 12,239,044 8,490,595